DGIdb - HTR2A Gene Record

HTR2A 3356 Druggable GenomeDrug Resistance

Alternate Names:

3356
5-HYDROXYTRYPTAMINE RECEPTOR 2A
HTR2A
5-HT2A
HTR2
182135
5293
ENSG00000102468
OTTHUMG00000016881
Serotonin receptor 2A
5-HT-2
5-HT-2A
P28223
5HT2A_HUMAN
BE0000451
PA193
6
5-HT<sub>2A</sub> receptor
BE0004881
5-HYDROXYTRYPTAMINE 2A RECEPTOR (5-HT-2A) (SEROTONIN RECEPTOR 2A) (5- HT-2). [SOURCE:UNIPROT/SWISSPROT;ACC:P28223]
BE0004957
5-HT 2A receptor
T32060
NP_000612
NM_000621

Gene Info:

Target Main Class	Receptors
Target Subclass	Rhodopsin
Transmembrane Helix Count	7
Target Subclass	GPCR
Human Readable Name	G PROTEIN COUPLED RECEPTOR
Interpro Acc	IPR000276
Uniprot Status	Swiss-Prot
Uniprot Evidence	1: Evidence at protein level
Interpro Name	GPCR, rhodopsin-like, 7TM
Interpro Type	Family
Human Readable Name	DRUGGABLE GENOME
Interpro Short Name	7TM_GPCR_Rhodpsn
Target Class	Receptors
Gene Biotype	PROTEIN_CODING
GuideToPharmacology Gene Category Name	5-Hydroxytryptamine receptors
GuideToPharmacology Gene Category ID	1

(13 More Sources)

Gene Categories: Category Details

KINASE
DRUG RESISTANCE
G PROTEIN COUPLED RECEPTOR
DRUGGABLE GENOME

Publications:

Roth et al., 1994, Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors., J. Pharmacol. Exp. Ther.
Yamada et al., 1995, Serotonin2 (5-HT2) receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) inhibits chlorpromazine- and haloperidol-induced hypothermia in mice., Biol. Pharm. Bull.
Kusumi et al., 2000, Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain., J Neural Transm (Vienna)
Tyson et al., 2004, Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors?, Int. J. Neurosci.
Maeda et al., 2014, Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator., J. Pharmacol. Exp. Ther.
Hesselink, 2002, Iloperidone (Novartis)., IDrugs
Kongsamut et al., 1996, Iloperidone binding to human and rat dopamine and 5-HT receptors., Eur. J. Pharmacol.
Berman et al., 2000, The Protein Data Bank., Nucleic Acids Res.
Serretti et al., Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders., J Psychiatr Res
Kvernmo et al., 2008, Receptor-binding and pharmacokinetic properties of dopaminergic agonists., Curr Top Med Chem
Sharif et al., 2009, Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes., Exp. Eye Res.
Sharif, 2010, Serotonin-2 receptor agonists as novel ocular hypotensive agents and their cellular and molecular mechanisms of action., Curr Drug Targets
Lam, 2000, Clinical pharmacology of dopamine agonists., Pharmacotherapy
Kumar B et al., 2018, Lumateperone: a new treatment approach for neuropsychiatric disorders., Drugs Today (Barc)
Wander et al., 1987, Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitro., Eur. J. Pharmacol.
Antkiewicz-Michaluk, The influence of chronic treatment with antidepressant neuroleptics on the central serotonin system., Pol J Pharmacol Pharm
Khalifa, 2003, Zuclopenthixol facilitates memory retrieval in rats: possible involvement of noradrenergic and serotonergic mechanisms., Pharmacol. Biochem. Behav.
Gjerden et al., 2009, Association between the use of anticholinergic antiparkinson drugs and safety and receptor drug-binding profiles of antipsychotic agents., Eur. J. Clin. Pharmacol.
Nyberg et al., 1995, Central D2 receptor occupancy and effects of zuclopenthixol acetate in humans., Int Clin Psychopharmacol
Lyon et al., 1986, 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors., Psychopharmacology (Berl.)
Nash et al., 1994, Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors., Neurosci. Lett.
Baxter et al., 1994, Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle., Br. J. Pharmacol.
Kaumann, 1983, Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors., Naunyn Schmiedebergs Arch. Pharmacol.
Leysen et al., 1994, Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity., J Clin Psychiatry
Kroeze et al., 2003, H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs., Neuropsychopharmacology
Nakamura et al., 2001, Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism., Eur. J. Pharmacol.
Kobayashi et al., 1996, Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems., Eur. J. Pharmacol.
Mestres J et al., 2011, Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome., Clin Pharmacol Ther
Honda et al., 2003, Tricyclic analogs cyclobenzaprine, amitriptyline and cyproheptadine inhibit the spinal reflex transmission through 5-HT(2) receptors., Eur. J. Pharmacol.
Grinshpoon et al., 2000, Beneficial effect of the addition of the 5-HT 2A/2C and alpha2 antagonist mianserin to ongoing haloperidol treatment in drug-resistant chronically hospitalized schizophrenic patients., Eur. Psychiatry
Deeks, 2015, Flibanserin: First Global Approval., Drugs
Invernizzi et al., 2003, Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors., Br. J. Pharmacol.
Borsini et al., 2002, Pharmacology of flibanserin., CNS Drug Rev
Peroutka et al., 1981, Two distinct central serotonin receptors with different physiological functions., Science
Dupont et al., 1996, Epinastine (WAL 801CL) modulates the noncholinergic contraction in guinea-pig airways in vitro by a prejunctional 5-HT1-like receptor., Eur. Respir. J.
Dupont et al., 1999, Epinastine (WAL 801CL) inhibits the electrical field stimulation-induced cholinergic contraction in guinea pig and human airways in vitro., Eur. Respir. J.
Shahid et al., 2009, Asenapine: a novel psychopharmacologic agent with a unique human receptor signature., J. Psychopharmacol. (Oxford)
Citrome, 2011, Role of sublingual asenapine in treatment of schizophrenia., Neuropsychiatr Dis Treat
Berger et al., 1996, Trimipramine: a challenge to current concepts on antidepressives., Eur Arch Psychiatry Clin Neurosci
Nasrallah, 2008, Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles., Mol. Psychiatry
Richelson et al., 2000, Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds., Life Sci.
McIntyre et al., 2007, A preclinical and clinical rationale for quetiapine in mood syndromes., Expert Opin Pharmacother
Goldstein, 1999, Quetiapine fumarate (Seroquel): a new atypical antipsychotic., Drugs Today
Yatham et al., 2005, Atypical antipsychotics in bipolar depression: potential mechanisms of action., J Clin Psychiatry
Rauser et al., 2001, Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor., J. Pharmacol. Exp. Ther.
Choi et al., 2004, Synthesis, receptor binding and functional studies of mesoridazine stereoisomers., Bioorg. Med. Chem. Lett.
Herrick-Davis et al., 2000, Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors., J. Pharmacol. Exp. Ther.
Hayslett et al., 2005, Effects of donepezil, nicotine and haloperidol on the central serotonergic system in mice: implications for Tourette's syndrome., Pharmacol. Biochem. Behav.
Hayslett et al., 2003, Effects of donepezil on DOI-induced head twitch response in mice: implications for Tourette syndrome., Pharmacol. Biochem. Behav.
Schreiber et al., 1994, Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone., Eur. J. Pharmacol.
Lindström et al., 2006, Sertindole: efficacy and safety in schizophrenia., Expert Opin Pharmacother
Hietala et al., 2001, Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment., Psychopharmacology (Berl.)
Reimold et al., 2007, Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol., Psychopharmacology (Berl.)
Kasho et al., 1998, Serotonin enhances the production of type IV collagen by human mesangial cells., Kidney Int.
Egan et al., 1998, Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors., Psychopharmacology (Berl.)
Murphy GM Jr et al., 2003, Pharmacogenetics of antidepressant medication intolerance., Am J Psychiatry
Wilkie MJ et al., 2009, Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy., Pharmacogenomics J
Foster RH et al., 1997, Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder., CNS Drugs
Meyer et al., 2001, The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study., Am J Psychiatry
Bixo et al., 2001, Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment., Psychoneuroendocrinology
Newcombe F et al., 1969, Alkaloids of the leaves of Voacanga schweinfurthii Stapf., Planta Med
Tanaka M et al., 2008, Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea., Int J Neuropsychopharmacol
Kato M et al., 2009, 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients., Psychiatry Res
Costall et al., 1995, Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations., Br. J. Pharmacol.
Morisset et al., 1999, Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade., J. Pharmacol. Exp. Ther.
Canton et al., 1994, Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics., Neurosci. Lett.
Andree et al., 1986, Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex., J. Neurochem.
Burki, 1986, Binding of psychoactive drugs to rat brain amine receptors, measured ex vivo, and their effects on the metabolism of biogenic amines., Naunyn Schmiedebergs Arch. Pharmacol.
Broderick et al., 2004, Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal., Prog. Neuropsychopharmacol. Biol. Psychiatry
McDonald et al., 2003, Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning., Psychopharmacology (Berl.)
Reist et al., 2004, Inter-relationships of intermediate phenotypes for serotonin function, impulsivity, and a 5-HT2A candidate allele: His452Tyr., Mol. Psychiatry
Arranz et al., 1996, Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine., Neurosci. Lett.
Salloum NC et al., 2014, Towards the clinical implementation of pharmacogenetics in bipolar disorder., BMC Med
Heiser et al., 2004, Effects of clozapine and its metabolites on the 5-HT2 receptor system in cortical and hippocampal cells in vitro., Prog. Neuropsychopharmacol. Biol. Psychiatry
Travis et al., 1998, 5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150., Br J Psychiatry
Muntasir HA et al., 2006, Inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonist, at the constitutively active human 5-HT2A receptor., J Pharmacol Sci
Friedman, 2013, Pimavanserin for the treatment of Parkinson's disease psychosis., Expert Opin Pharmacother
Bortolozzi et al., 2007, In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain., Psychopharmacology (Berl.)
Meltzer et al., 2003, Serotonin receptors: their key role in drugs to treat schizophrenia., Prog. Neuropsychopharmacol. Biol. Psychiatry
Stark et al., 2007, Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies., Psychopharmacology (Berl.)
de Bartolomeis A et al., 2015, Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism., CNS Drugs
Pawlyk AC et al., 2006, Effects of the 5-HT2A antagonist mirtazapine in rat models of thermoregulation., Brain Res
Celada P et al., 2004, The therapeutic role of 5-HT1A and 5-HT2A receptors in depression., J Psychiatry Neurosci
Nutt, 1999, Care of depressed patients with anxiety symptoms., J Clin Psychiatry
Anttila et al., 2001, A review of the pharmacological and clinical profile of mirtazapine., CNS Drug Rev
Waldinger et al., 2000, Treatment of hot flushes with mirtazapine: four case reports., Maturitas
Gorman, 1999, Mirtazapine: clinical overview., J Clin Psychiatry
Westenberg, 1999, Pharmacology of antidepressants: selectivity or multiplicity?, J Clin Psychiatry
Laakmann et al., 1999, Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects., Psychoneuroendocrinology
Deeks ED et al., 2010, Blonanserin: a review of its use in the management of schizophrenia., CNS Drugs
Bisson WH et al., 2007, Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs., Proc Natl Acad Sci U S A
Martin et al., 1982, Ketamine inhibits serotonin uptake in vivo., Neuropharmacology
Yamada et al., 2002, Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D(2) receptor occupancy., Synapse
Cohen, Risperidone., Pharmacotherapy
Megens et al., 1994, Survey on the pharmacodynamics of the new antipsychotic risperidone., Psychopharmacology (Berl.)
He et al., 1995, A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors., Int Clin Psychopharmacol
Taylor et al., 1995, Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug., J Clin Psychiatry
Horton et al., 1999, Akinetopsia from nefazodone toxicity., Am. J. Ophthalmol.
Eckler et al., 2003, Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control., Pharmacol. Biochem. Behav.
Avila et al., 2003, Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial., J Clin Psychopharmacol
Cusack et al., 1994, Binding of antidepressants to human brain receptors: focus on newer generation compounds., Psychopharmacology (Berl.)
Meyer et al., 1999, The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET., Psychopharmacology (Berl.)
Davis et al., 1997, Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression., Drugs
Hidalgo et al., 1999, Nefazodone in post-traumatic stress disorder: results from six open-label trials., Int Clin Psychopharmacol
Zanoveli et al., 2005, Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety., Behav Pharmacol
Keks et al., 1999, Risperidone (Risperdal): clinical experience with a new antipsychosis drug., Expert Opin Investig Drugs
López-Rodríguez R et al., 2013, Pharmacodynamic genetic variants related to antipsychotic adverse reactions in healthy volunteers., Pharmacogenomics
Uchida et al., 2007, Brain neurotransmitter receptor-binding characteristics in rats after oral administration of haloperidol, risperidone and olanzapine., Life Sci.
Angelucci F et al., 2009, Delusion symptoms and response to antipsychotic treatment are associated with the 5-HT2A receptor polymorphism (102T/C) in Alzheimer's disease: a 3-year follow-up longitudinal study., J Alzheimers Dis
Correia CT et al., 2010, Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions., Pharmacogenomics J
Corena-McLeod M, 2015, Comparative Pharmacology of Risperidone and Paliperidone., Drugs R D
Fenton et al., 2005, Risperidone: a review of its use in the treatment of bipolar mania., CNS Drugs
Maffioletti E et al., 2020, Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients., Drug Dev Res
Ujike H et al., 2008, Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study., J Clin Psychiatry
Sharpley et al., 2005, Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients., J Clin Psychiatry
Padín et al., 2006, Parallel regulation by olanzapine of the patterns of expression of 5-HT2A and D3 receptors in rat central nervous system and blood cells., Neuropharmacology
Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
Moresco et al., 2004, Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine., J. Psychopharmacol. (Oxford)
Brafford MV et al., 2014, Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting., J Adv Pract Oncol
Thomas P et al., 2008, Correlates of response to Olanzapine in a North Indian Schizophrenia sample., Psychiatry Res
Laika B et al., 2010, Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome., Pharmacogenomics J
Bymaster et al., 1999, Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro., Schizophr. Res.
Aly SA et al., 2009, Assessment of binding affinity to 5-hydroxytryptamine 2A (5-HT2A) receptor and inverse agonist activity of naftidrofuryl: comparison with those of sarpogrelate., J Pharmacol Sci
Govitrapong et al., 2002, Platelet serotonin transporter in schizophrenic patients with and without neuroleptic treatment., Neurochem. Int.
Kim DH et al., 2009, Building a better antipsychotic: receptor targets for the treatment of multiple symptom dimensions of schizophrenia., Neurotherapeutics
Govitrapong et al., 2000, Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment., Psychiatry Res
Overington et al., 2006, How many drug targets are there?, Nat Rev Drug Discov
Imming et al., 2006, Drugs, their targets and the nature and number of drug targets., Nat Rev Drug Discov
Nguyen et al., 1989, Down-regulation of tryptamine binding sites following chronic molindone administration. A comparison with responses of dopamine and 5-hydroxytryptamine receptors., Naunyn Schmiedebergs Arch. Pharmacol.
Prins et al., 2001, Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle., Br. J. Pharmacol.
Castilho et al., 1999, Antinociception elicited by aversive stimulation of the inferior colliculus., Pharmacol. Biochem. Behav.
Connor et al., 2001, Second messengers in platelet aggregation evoked by serotonin and A23187, a calcium ionophore., Life Sci.
Geerts et al., 1999, Involvement of 5-HT1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery., Br. J. Pharmacol.
Shaw et al., 2000, Role of the 5-HT(2A)receptor and alpha(1)-adrenoceptor in the contractile response of rat pulmonary artery to 5-HT in the presence and absence of nitric oxide., Pulm Pharmacol Ther
Cussac et al., 2008, Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells., Eur. J. Pharmacol.
LeWitt PA, 2004, Subcutaneously administered apomorphine: pharmacokinetics and metabolism., Neurology
Görnemann T et al., 2008, Characterization of the molecular fragment that is responsible for agonism of pergolide at serotonin 5-Hydroxytryptamine2B and 5-Hydroxytryptamine2A receptors., J Pharmacol Exp Ther
Wander et al., 1986, Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro., Eur. J. Pharmacol.
Richelson et al., 1984, Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro., J. Pharmacol. Exp. Ther.
Tatsumi et al., 1997, Pharmacological profile of antidepressants and related compounds at human monoamine transporters., Eur. J. Pharmacol.
Sargent et al., 1998, Clomipramine enhances the cortisol response to 5-HTP: implications for the therapeutic role of 5-HT2 receptors., Psychopharmacology (Berl.)
Hentall et al., 2000, Correlations between serotonin level and single-cell firing in the rat's nucleus raphe magnus., Neuroscience
Trifunović et al., 1996, The effects of clomipramine on the excitatory action of ethanol on dopaminergic neurons of the ventral tegmental area in vitro., J. Pharmacol. Exp. Ther.
Contreras et al., Cortical and septal responses to dorsal raphe nucleus stimulation in the rat: long-term clomipramine actions., Bol Estud Med Biol
Sugimoto et al., 2003, The tricyclic antidepressant clomipramine increases plasma glucose levels of mice., J. Pharmacol. Sci.
Bizière et al., 1985, Minaprine, a new drug with antidepressant properties., Drugs Exp Clin Res
Nabeshima et al., 1989, Effect of minaprine on cycloheximide-induced amnesia in mice., Eur. J. Pharmacol.
Muramatsu et al., 1988, 5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices., Eur. J. Pharmacol.
Kodama et al., 1992, Protective effect of minaprine against the abnormal changes of 2-deoxyglucose uptake by rat hippocampal slices induced by hypoxia/hypoglycemia., Jpn. J. Pharmacol.
Svartengren et al., 1990, Receptor binding properties of amperozide., Pharmacol. Toxicol.
George et al., 2013, Newer antipsychotics and upcoming molecules for schizophrenia., Eur. J. Clin. Pharmacol.
Green et al., 2004, Focus on levomepromazine., Curr Med Res Opin
Kanerva et al., 1999, Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration--a positron emission tomography study., Psychopharmacology (Berl.)
Uher R et al., 2009, Genetic predictors of response to antidepressants in the GENDEP project., Pharmacogenomics J
Sanchez C et al., 2014, A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?, Int Clin Psychopharmacol
Li et al., 2003, A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens., Psychopharmacology (Berl.)
Panconesi et al., 1994, Comparison between venoconstrictor effects of sumatriptan and ergotamine in migraine patients., Headache
Bom et al., 1989, Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5-HT1-like or 5-HT2 receptors., Br. J. Pharmacol.
Schotte et al., 1996, Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding., Psychopharmacology (Berl.)
Seeman et al., 1997, Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors., Neuropsychopharmacology
Sharma A et al., 2003, Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird's eye view., Curr Drug Metab
Adolph O et al., 2012, Promethazine inhibits NMDA-induced currents - new pharmacological aspects of an old drug., Neuropharmacology
POWE CE et al., 1962, Propiomazine hydrochloride in obstetrical analgesia. A controlled study of 520 patients., JAMA
Beubler et al., 1990, Stimulatory effects of 5-hydroxytryptamine on fluid secretion and transmural potential difference in rat small intestine are mediated by different receptor subtypes., J. Pharm. Pharmacol.
Nieto et al., 2000, In vitro effects of 5-hydroxytryptamine and cisapride on the circular smooth muscle of the jejunum of horses., Am. J. Vet. Res.
Cushing et al., 1993, Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity., J. Pharmacol. Exp. Ther.
Tiwari AK et al., 2013, Analysis of 34 candidate genes in bupropion and placebo remission., Int J Neuropsychopharmacol
Pälvimäki et al., 1996, Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor., Psychopharmacology (Berl.)
Kast et al., 2007, Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone., Bone Marrow Transplant.
Mamo et al., 2004, A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone., Am J Psychiatry
Lu et al., 2002, A case of ziprasidone-induced mania and the role of 5-HT2A in mood changes induced by atypical antipsychotics., J Clin Psychiatry
Mansbach et al., Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone., Pharmacol. Biochem. Behav.
Ichikawa et al., 2002, Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism., Brain Res.
Stahl et al., 2003, The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice., J Clin Psychiatry
Rashid et al., 2002, Effects of sarpogrelate, a novel 5-HT2 antagonist, on 5-HT-induced endothelium-dependent relaxations in porcine coronary artery., Jpn. J. Pharmacol.
Calka et al., Effect of cyproheptadine on serum leptin levels., Adv Ther
Hoenicke et al., 1992, The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors., J. Pharmacol. Exp. Ther.
Callaway et al., 1992, Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine., Neuropsychopharmacology
Alarcón de la Lastra et al., 1998, Effects of cinitapride on gastric ulceration and secretion in rats., Inflamm. Res.
Alarcón-de-la-Lastra Romero et al., 1997, Cinitapride protects against ethanol-induced gastric mucosal injury in rats: role of 5-hydroxytryptamine, prostaglandins and sulfhydryl compounds., Pharmacology
Ivgy-May et al., 2015, Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial., Sleep Med.
Bravo L et al., 2019, Monoamines as Drug Targets in Chronic Pain: Focusing on Neuropathic Pain., Front Neurosci
Sánchez et al., 1999, Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding., Cell. Mol. Neurobiol.
Sánchez Martín A et al., 2013, Impact of pharmacogenetics on CNS side effects related to efavirenz., Pharmacogenomics
Beattie et al., 2004, The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo., Br. J. Pharmacol.
McCormack, 2015, Cariprazine: First Global Approval., Drugs
Pazzagli et al., 1999, Trazodone increases extracellular serotonin levels in the frontal cortex of rats., Eur. J. Pharmacol.
Conn et al., 1987, Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors., J. Pharmacol. Exp. Ther.
Luparini et al., 2004, A cortical GABA-5HT interaction in the mechanism of action of the antidepressant trazodone., Prog. Neuropsychopharmacol. Biol. Psychiatry
Marek et al., 1992, A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action., Psychopharmacology (Berl.)
Marcoli et al., 2001, Inhibitory presynaptic 5-hydroxytryptamine(2A) receptors regulate evoked glutamate release from rat cerebellar mossy fibers., J. Pharmacol. Exp. Ther.
Balsara JJ et al., 2005, Effects of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on dopamine-dependent behaviors in rats., Psychopharmacology (Berl)
Stryjer R et al., 2003, Treatment of neuroleptic-induced akathisia with the 5-HT2A antagonist trazodone., Clin Neuropharmacol
Cargnin S et al., 2014, Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache., Eur J Clin Pharmacol
Stahl, 2008, Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines., CNS Spectr
Maj et al., 1977, Doxepin as a blocker of central serotonin receptors., Pharmakopsychiatr Neuropsychopharmakol
Lohoff FW et al., 2013, Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder., Pharmacogenomics J
Smith RM et al., 2013, Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex., Biol Psychiatry
Illi A et al., 2009, 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression., Neuroreport
Demirbugen Oz M et al., 2018, The relationship between the serotonin 2A receptor gene -1438A/G and 102T/C polymorphisms and citalopram/sertraline-induced nausea in major depressed patients., Hum Psychopharmacol
Paddock S et al., 2007, Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort., Am J Psychiatry
Pandey DK et al., 2010, A novel 5-HT(2A) receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants., Pharmacol Biochem Behav
Riga MS et al., 2016, The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT(1A) and 5-HT(2A) receptors., Neuropharmacology
Kato M et al., 2006, Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients., Neuropsychobiology
Suzuki Y et al., 2006, Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients., Neuropsychopharmacology
Fulton A et al., 1982, Assessment of the antidepressant activity of dothiepin and its metabolites by preclinical tests., J Affect Disord
Abelaira HM et al., 2012, Lamotrigine treatment reverses depressive-like behavior and alters BDNF levels in the brains of maternally deprived adult rats., Pharmacol Biochem Behav
Ibeas Bih C et al., 2015, Molecular Targets of Cannabidiol in Neurological Disorders., Neurotherapeutics
Kishi T et al., 2013, Efficacy and tolerability of perospirone in schizophrenia: a systematic review and meta-analysis of randomized controlled trials., CNS Drugs
Tanaka H et al., 1998, Localization and pharmacological characterization of [3H]perospirone-binding sites in rat brain., Gen Pharmacol
Belcheva S et al., 1995, Effects on nociception of the Ca2+ and 5-HT antagonist dotarizine and other 5-HT receptor agonists and antagonists., Acta Physiol Pharmacol Bulg
Farré M et al., 1997, Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration., Methods Find Exp Clin Pharmacol
Przegaliński E et al., 1979, The central action of pizotifen., Psychopharmacology (Berl)
Mylecharane EJ, 1991, 5-HT2 receptor antagonists and migraine therapy., J Neurol
Fitzgerald et al., 2000, Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine., Mol. Pharmacol.
Rubio-Beltrán E et al., 2018, Is selective 5-HT<sub>1F</sub> receptor agonism an entity apart from that of the triptans in antimigraine therapy?, Pharmacol Ther
Morales P et al., 2017, An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol., Front Pharmacol
Jarema M et al., 2011, [Trazodon--the antidepressant: mechanism of action and its position in the treatment of depression]., Psychiatr Pol
Acuña-Castillo C et al., 2000, ALEPH-2, a suspected anxiolytic and putative hallucinogenic phenylisopropylamine derivative, is a 5-HT2a and 5-HT2c receptor agonist., Life Sci
Villalobos CA et al., 2004, 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes., Br J Pharmacol
Moya PR et al., 2007, Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors., J Pharmacol Exp Ther
Fleckenstein et al., 2007, New insights into the mechanism of action of amphetamines., Annu. Rev. Pharmacol. Toxicol.
Kokoshka et al., 1998, Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain., Brain Res.
Haughey et al., 2000, The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia., J. Neurochem.
Su et al., 2009, When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor., Sci Signal
Pierce et al., 1989, Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex., Psychopharmacology (Berl.)

NELOTANSERIN HTR2A

Interaction Score: 0.9

Interaction Types & Directionality:

inverse agonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor inverse agonist

Direct Interaction yes

PMIDs:
None found

Sources:
TTD DrugBank ChemblInteractions
PIMAVANSERIN HTR2A

Interaction Score: 0.75

Interaction Types & Directionality:

inverse agonist (inhibitory)

antagonist (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name Pimavanserin

Details of the Assay for Interaction Ki determined in membrane radioligand binding assay.

PMIDs:
24016069

Sources:
TdgClinicalTrial TTD DrugBank GuideToPharmacology
TEMANOGREL HTR2A

Interaction Score: 0.6

Interaction Types & Directionality:

inverse agonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor inverse agonist

Direct Interaction yes

PMIDs:
None found

Sources:
TTD ChemblInteractions
PRUVANSERIN HTR2A

Interaction Score: 0.6

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
TTD ChemblInteractions
IFERANSERIN HTR2A

Interaction Score: 0.6

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name iferanserin ointment

Novel drug target Established target

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

PMIDs:
None found

Sources:
TdgClinicalTrial ChemblInteractions
CHEMBL292821 HTR2A

Interaction Score: 0.45

Interaction Types & Directionality:

partial agonist (activating)

Interaction Info:

PMIDs:
15006903 17337633

Sources:
DrugBank
BUTRIPTYLINE HTR2A

Interaction Score: 0.4

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
3816971 6086881 9537821

Sources:
DrugBank
BLONANSERIN HTR2A

Interaction Score: 0.4

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

Direct Interaction? True

PMIDs:
20030420

Sources:
TTD DrugBank GuideToPharmacology
SARPOGRELATE HTR2A

Interaction Score: 0.37

Interaction Types & Directionality:

inverse agonist (inhibitory)

antagonist (inhibitory)

Interaction Info:

Endogenous Drug? False

Specific Action of the Ligand Antagonist

PMIDs:
19672037 17031071

Sources:
TTD DrugBank GuideToPharmacology
N,N-DIMETHYLTRYPTAMINE HTR2A

Interaction Score: 0.3

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
19278957 2540505

Sources:
DrugBank
CHEMBL339611 HTR2A

Interaction Score: 0.3

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
11191631

Sources:
DrugBank
VOLINANSERIN HTR2A

Interaction Score: 0.3

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

Trial Name volinanserin

PMIDs:
None found

Sources:
TdgClinicalTrial GuideToPharmacology ChemblInteractions
EPLIVANSERIN HTR2A

Interaction Score: 0.3

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
DrugBank ChemblInteractions
CINITAPRIDE HTR2A

Interaction Score: 0.3

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
9562338 9211565

Sources:
DrugBank
PIMAVANSERIN TARTRATE HTR2A

Interaction Score: 0.3

Interaction Types & Directionality:

inverse agonist (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor inverse agonist

PMIDs:
None found

Sources:
ChemblInteractions
AMESERGIDE HTR2A

Interaction Score: 0.3

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
SERGOLEXOLE HTR2A

Interaction Score: 0.3

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
DERAMCICLANE HTR2A

Interaction Score: 0.3

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
10445375

Sources:
DrugBank
NEMIFITIDE HTR2A

Interaction Score: 0.3

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name INN-00835, nemifitide

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial
MESORIDAZINE HTR2A

Interaction Score: 0.26

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

Direct Interaction? False

PMIDs:
11561066 15357957 10991983

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology
TRAZODONE HTR2A

Interaction Score: 0.26

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name trazodone extended release, DDS-04A,Oleptro

Specific Action of the Ligand Antagonist

PMIDs:
10594316 3039120 15610924 1365657 7855217 11714900 15614572 12782915

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology
LUMATEPERONE HTR2A

Interaction Score: 0.26

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name ITI-007, ITI-722

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

PMIDs:
30596390

Sources:
TdgClinicalTrial TTD DrugBank GuideToPharmacology ChemblInteractions
THIOTHIXENE HTR2A

Interaction Score: 0.25

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction? True

Endogenous Drug? False

Specific Action of the Ligand Antagonist

PMIDs:
8593484 10821438

Sources:
DrugBank GuideToPharmacology ChemblInteractions
NEFAZODONE HTR2A

Interaction Score: 0.24

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

Specific Action of the Ligand Antagonist

PMIDs:
7649970 10577608 12873632 14520130 7855217 10435395 9098663 10220119

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology
MINAPRINE HTR2A

Interaction Score: 0.23

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
3836113 2530096 2975224 1361012

Sources:
TEND TdgClinicalTrial DrugBank
CHEMBL126506 HTR2A

Interaction Score: 0.22

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
17209801 9666084 17139284 10987842 17016423

Sources:
DrugBank
DOTARIZINE HTR2A

Interaction Score: 0.22

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
8830881 9379783

Sources:
DrugBank
ESMIRTAZAPINE HTR2A

Interaction Score: 0.22

Interaction Types & Directionality:

inverse agonist (inhibitory)

Interaction Info:

Trial Name esmirtazapine, ORG-4420

Novel drug target Established target

PMIDs:
26047892

Sources:
TdgClinicalTrial DrugBank
PIPOTIAZINE HTR2A

Interaction Score: 0.22

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
8593484 10821438

Sources:
DrugBank
FLIBANSERIN HTR2A

Interaction Score: 0.21

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Direct Interaction? True

Endogenous Drug? False

PMIDs:
26412054 12890707 12177684

Sources:
TdgClinicalTrial TTD DrugBank GuideToPharmacology
CISAPRIDE HTR2A

Interaction Score: 0.2

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
1969947 11131599 8423526

Sources:
DrugBank
AMPEROZIDE HTR2A

Interaction Score: 0.2

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
2154737

Sources:
DrugBank
TRELANSERIN HTR2A

Interaction Score: 0.2

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

Trial Name trelanserin, SL 65.0472

PMIDs:
None found

Sources:
TdgClinicalTrial ChemblInteractions
PROPIOMAZINE HTR2A

Interaction Score: 0.19

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
12678691 19110200 17139284 17016423 22507664 14488364

Sources:
TEND TdgClinicalTrial DrugBank
CYPROHEPTADINE HTR2A

Interaction Score: 0.18

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
12498911 12233819 16418149 1403790 1358088

Sources:
TEND TdgClinicalTrial DrugBank
MIRTAZAPINE HTR2A

Interaction Score: 0.18

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

Trial Name mirtazapine,Remeron, Remeron SolTab, Reflex

PMIDs:
17067560 15309042 10446738 11607047 11063897 10446735 10446734 10451911

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology ChemblInteractions
MIDOMAFETAMINE HTR2A

Interaction Score: 0.17

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
2871581 7824160

Sources:
TTD DrugBank
BREXPIPRAZOLE HTR2A

Interaction Score: 0.17

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

Trial Name OPC-34712

PMIDs:
24947465

Sources:
TdgClinicalTrial DrugBank ChemblInteractions
CYCLOBENZAPRINE HTR2A

Interaction Score: 0.16

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
8884233 21975349 12498911

Sources:
TEND TdgClinicalTrial TTD DrugBank
METHYSERGIDE HTR2A

Interaction Score: 0.16

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

Trial Name -

PMIDs:
11704657 10080233 11720080 10455282 11061982

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology
ROLUPERIDONE HYDROCHLORIDE HTR2A

Interaction Score: 0.15

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TTD
MOLINDONE HYDROCHLORIDE HTR2A

Interaction Score: 0.15

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
ASENAPINE MALEATE HTR2A

Interaction Score: 0.15

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
ABAPERIDONE HTR2A

Interaction Score: 0.15

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TTD
BL-1020 HTR2A

Interaction Score: 0.15

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DrugBank
LURASIDONE HTR2A

Interaction Score: 0.15

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name lurasidone, SM-13496,Latuda

Novel drug target Established target

PMIDs:
23545936

Sources:
TdgClinicalTrial DrugBank
MESORIDAZINE BESYLATE HTR2A

Interaction Score: 0.15

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
LURASIDONE HYDROCHLORIDE HTR2A

Interaction Score: 0.15

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
RISPERDAL HTR2A

Interaction Score: 0.15

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name Risperdal

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial
THIOPROPERAZINE HTR2A

Interaction Score: 0.15

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
8593484 10821438

Sources:
DrugBank
SB-773812 HTR2A

Interaction Score: 0.15

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

PMIDs:
None found

Sources:
ChemblInteractions
PALIPERIDONE HTR2A

Interaction Score: 0.14

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name paliperidone ER, paliperidone palmitate

Novel drug target Established target

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

PMIDs:
11132243 12211096 7520908 7524043 7531353 7542676

Sources:
TEND TdgClinicalTrial DrugBank ChemblInteractions
THIORIDAZINE HTR2A

Interaction Score: 0.14

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction? True

Endogenous Drug? False

Specific Action of the Ligand Antagonist

PMIDs:
8680734 9918563 7898773 2866233 2423886

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology ChemblInteractions
CHLORPROTHIXENE HTR2A

Interaction Score: 0.14

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

PMIDs:
2891550 3774629

Sources:
TEND TdgClinicalTrial DrugBank ChemblInteractions
PROMAZINE HTR2A

Interaction Score: 0.13

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
12106771 19110200 10980325 17139284 17016423

Sources:
TEND TdgClinicalTrial DrugBank
ZUCLOPENTHIXOL HTR2A

Interaction Score: 0.13

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
12957216 19644682 8748043

Sources:
DrugBank
PEROSPIRONE HTR2A

Interaction Score: 0.13

Interaction Types & Directionality:

inverse agonist (inhibitory)

Interaction Info:

PMIDs:
23812802 9595296

Sources:
DrugBank
MOLINDONE HTR2A

Interaction Score: 0.13

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction? True

Endogenous Drug? False

Specific Action of the Ligand Antagonist

PMIDs:
2586632

Sources:
DrugBank GuideToPharmacology
EPINASTINE HTR2A

Interaction Score: 0.13

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
8836655 10596692

Sources:
DrugBank
TEGASEROD HTR2A

Interaction Score: 0.12

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
15466450

Sources:
DrugBank
ACEPROMAZINE HTR2A

Interaction Score: 0.11

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
8593484 10821438

Sources:
DrugBank
ILOPERIDONE HTR2A

Interaction Score: 0.11

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Novel drug target Established target

PMIDs:
12861482 8997630

Sources:
TdgClinicalTrial TTD DrugBank ChemblInteractions
SERTINDOLE HTR2A

Interaction Score: 0.11

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name Serdolect

Novel drug target Established target

Specific Action of the Ligand Antagonist

PMIDs:
7530204 16925508 11594443

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology
CLOMIPRAMINE HTR2A

Interaction Score: 0.11

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
9862411 10682715 8558452 1296670 14501155

Sources:
DrugBank
LORPIPRAZOLE HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
22232986

Sources:
DrugBank
FENFLURAMINE HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10617681

Sources:
DrugBank
ETOPERIDONE HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
7855217

Sources:
DrugBank
QUETIAPINE FUMARATE HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
ZIPRASIDONE HYDROCHLORIDE HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
CHEMBL473186 HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
5-MEO-DMT HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
26477571

Sources:
DrugBank
ZIPRASIDONE MESYLATE HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
BUFOTENINE HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
PERGOLIDE HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

PMIDs:
18703043 18691132 10641988 18096760

Sources:
DrugBank GuideToPharmacology
GLEMANSERIN HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Endogenous Drug? False

Specific Action of the Ligand Antagonist

PMIDs:
None found

Sources:
GuideToPharmacology
ARIPIPRAZOLE LAUROXIL HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
RELENOPRIDE HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

Direct Interaction? False

PMIDs:
None found

Sources:
GuideToPharmacology
VABICASERIN HYDROCHLORIDE HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
RS-102,221 HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
THIOTHIXENE HYDROCHLORIDE HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
LORCASERIN HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
BROLAMFETAMINE HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
CARPHENAZINE MALEATE HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

PMIDs:
None found

Sources:
ChemblInteractions
ANIRACETAM HTR2A

Interaction Score: 0.1

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11412837

Sources:
TTD DrugBank
ZIPRASIDONE HTR2A

Interaction Score: 0.09

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction? True

Endogenous Drug? False

Specific Action of the Ligand Antagonist

PMIDs:
17450180 15121646 12530423 11509214 17848919 12445705 14728084

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology
OLANZAPINE HTR2A

Interaction Score: 0.09

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv

Novel drug target Established target

Trial Name Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac)

PMIDs:
19193342 14530903 17316700 17848919 15816787 19494443 16905159 11752352 15358979 25032030 24885933 19000940 19636338 32462699 10227113 16038601

Sources:
TEND PharmGKB TdgClinicalTrial DrugBank GuideToPharmacology ChemblInteractions
CABERGOLINE HTR2A

Interaction Score: 0.09

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

PMIDs:
18691132 18992242 20426763 10641988

Sources:
DrugBank GuideToPharmacology
ERGOTAMINE HTR2A

Interaction Score: 0.09

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Partial agonist

Endogenous Drug? False

PMIDs:
11752352 8014033 2758221

Sources:
DrugBank GuideToPharmacology
PAROXETINE HTR2A

Interaction Score: 0.09

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
14514498 18253134 23338224 11136637 11403977 5821956 17697394 19361869

Sources:
PharmGKB DrugBank
FLUVOXAMINE HTR2A

Interaction Score: 0.09

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
16874005 16205777 19361869

Sources:
PharmGKB
CARIPRAZINE HTR2A

Interaction Score: 0.09

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
26510944

Sources:
DrugBank
ASENAPINE HTR2A

Interaction Score: 0.08

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name Asenapine

Novel drug target Established target

Specific Action of the Ligand Antagonist

PMIDs:
18308814 21655346 10592235

Sources:
TdgClinicalTrial DrugBank GuideToPharmacology
PIPAMPERONE HTR2A

Interaction Score: 0.07

Interaction Types & Directionality:

agonist (activating)

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
8935801

Sources:
DrugBank GuideToPharmacology
HALOPERIDOL LACTATE HTR2A

Interaction Score: 0.07

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
QUIPAZINE HTR2A

Interaction Score: 0.07

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
ZICRONAPINE HTR2A

Interaction Score: 0.07

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TTD
CYAMEMAZINE HTR2A

Interaction Score: 0.07

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
KETANSERIN HTR2A

Interaction Score: 0.07

Interaction Types & Directionality:

inverse agonist (inhibitory)

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

Direct Interaction? False

PMIDs:
9767524 17031071

Sources:
NCI DrugBank GuideToPharmacology
HALOPERIDOL DECANOATE HTR2A

Interaction Score: 0.07

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
LISURIDE HTR2A

Interaction Score: 0.07

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Partial agonist

Endogenous Drug? False

PMIDs:
18691132 9600588

Sources:
DrugBank GuideToPharmacology
DONEPEZIL HTR2A

Interaction Score: 0.07

Interaction Types & Directionality:

inducer (activating)

Interaction Info:

PMIDs:
16045972 14643839

Sources:
DrugBank
RISPERIDONE HTR2A

Interaction Score: 0.07

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

Specific Action of the Ligand Inverse agonist

PMIDs:
15992090 23859574 17316700 11132243 19494443 19997080 25943458 15907153 32462699

Sources:
TEND PharmGKB TdgClinicalTrial DrugBank GuideToPharmacology ChemblInteractions
ZOLMITRIPTAN HTR2A

Interaction Score: 0.07

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
29352859

Sources:
DrugBank
DOXEPIN HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name Silenor (SO-101)

Novel drug target Established target

PMIDs:
19179941 309138 7855217

Sources:
TdgClinicalTrial DrugBank
LYSERGIDE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
OLANZAPINE PAMOATE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
LOXAPINE HYDROCHLORIDE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
CYCLOBENZAPRINE HYDROCHLORIDE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
REMOXIPRIDE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

other/unknown

Interaction Info:

PMIDs:
9015795

Sources:
DrugBank
RENZAPRIDE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

n/a

Interaction Info:

Novel drug target Established target

Trial Name renzapride

PMIDs:
None found

Sources:
TdgClinicalTrial
MESULERGINE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
CLOZAPINE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Inverse agonist

Endogenous Drug? False

Direct Interaction? True

PMIDs:
14687870 14530903 15037867 8916101 7520908 12973385 24885933 14751426 9926100

Sources:
NCI TEND PharmGKB TdgClinicalTrial DrugBank GuideToPharmacology ChemblInteractions
FLUPENTIXOL HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
17111172

Sources:
DrugBank
TRAZODONE HYDROCHLORIDE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

PMIDs:
None found

Sources:
ChemblInteractions
OCAPERIDONE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10592235

Sources:
TTD DrugBank
QUETIAPINE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

agonist (activating)

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

Specific Action of the Ligand Antagonist

PMIDs:
17848919 11132243 17563257 12973385 16038601

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology
ARIPIPRAZOLE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

partial agonist (activating)

agonist (activating)

antagonist (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Specific Action of the Ligand Partial agonist

PMIDs:
17265076 14642974 17242925 26346901

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology ChemblInteractions
PIZOTYLINE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
111296 2045831

Sources:
DrugBank
ZOTEPINE HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Endogenous Drug? False

Specific Action of the Ligand Antagonist

PMIDs:
None found

Sources:
TTD DrugBank GuideToPharmacology
MIANSERIN HTR2A

Interaction Score: 0.06

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction? True

Endogenous Drug? False

Specific Action of the Ligand Antagonist

PMIDs:
11004734

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology
THIETHYLPERAZINE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
None found

Sources:
TEND TdgClinicalTrial
AMISULPRIDE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
15204055

Sources:
DrugBank
DOTHIEPIN HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
6215444

Sources:
DrugBank
NEFAZODONE HYDROCHLORIDE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
LOXAPINE SUCCINATE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
ESMIRTAZAPINE MALEATE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
TRYPTAMINE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? True

PMIDs:
None found

Sources:
TTD GuideToPharmacology
BIFEPRUNOX HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name bifeprunox, DU127090

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial
NORTRIPTYLINE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
7855217 31942167 10379421

Sources:
DrugBank
APOMORPHINE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

agonist (activating)

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
15037665 18691132

Sources:
DrugBank GuideToPharmacology
CHEMBL309760 HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Endogenous Drug? False

Specific Action of the Ligand Full agonist

PMIDs:
None found

Sources:
GuideToPharmacology
FLUPHENAZINE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
17606915

Sources:
DrugBank GuideToPharmacology
SPIRAMIDE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
AGOMELATINE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
YOHIMBINE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
8032658 6136920

Sources:
DrugBank
BROMOCRIPTINE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Partial agonist

Endogenous Drug? False

PMIDs:
18703043 18691132 10641988

Sources:
DrugBank GuideToPharmacology
ESCITALOPRAM HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

PMIDs:
19365399 24424469

Sources:
PharmGKB DrugBank
TERGURIDE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Partial agonist

Endogenous Drug? False

Trial Name terguride

PMIDs:
None found

Sources:
TdgClinicalTrial GuideToPharmacology
ONDANSETRON HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
9767524

Sources:
NCI
LOXAPINE HTR2A

Interaction Score: 0.05

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name AZ-004

Novel drug target Established target

Specific Action of the Ligand Inverse agonist

PMIDs:
12664192

Sources:
TdgClinicalTrial DrugBank GuideToPharmacology ChemblInteractions
CHLORPROMAZINE HTR2A

Interaction Score: 0.04

Interaction Types & Directionality:

binder

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

Specific Action of the Ligand Inverse agonist

PMIDs:
7908055 8593484 10821438

Sources:
DrugBank GuideToPharmacology ChemblInteractions
CITALOPRAM HTR2A

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
23158458 19590397 30221791 17671280

Sources:
PharmGKB
DROPERIDOL HTR2A

Interaction Score: 0.04

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

PMIDs:
None found

Sources:
ChemblInteractions
TRIMIPRAMINE MALEATE HTR2A

Interaction Score: 0.04

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
RITANSERIN HTR2A

Interaction Score: 0.04

Interaction Types & Directionality:

inverse agonist (inhibitory)

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
17031071

Sources:
DrugBank GuideToPharmacology
MK-212 HTR2A

Interaction Score: 0.04

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
FLUSPIRILENE HTR2A

Interaction Score: 0.04

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
8935801

Sources:
DrugBank GuideToPharmacology
SEROTONIN HTR2A

Interaction Score: 0.04

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Endogenous Drug? True

Specific Action of the Ligand Full agonist

PMIDs:
7221567

Sources:
DrugBank GuideToPharmacology
VENLAFAXINE HTR2A

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22006095

Sources:
PharmGKB
PINDOLOL HTR2A

Interaction Score: 0.04

Interaction Types & Directionality:

agonist (activating)

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

Specific Action of the Ligand Antagonist

PMIDs:
None found

Sources:
GuideToPharmacology
PROMAZINE HYDROCHLORIDE HTR2A

Interaction Score: 0.04

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
DONITRIPTAN HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
SUMATRIPTAN HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
25096645

Sources:
PharmGKB
BRL-15,572 HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
CAPESEROD HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Endogenous Drug? False

Specific Action of the Ligand Partial agonist

PMIDs:
None found

Sources:
GuideToPharmacology
BUPROPION HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22947179

Sources:
PharmGKB
KETAMINE HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
6460944

Sources:
DrugBank
QUINPIROLE HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
AMITRIPTYLINE HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name OMS-103HP

Novel drug target Established target

PMIDs:
19800913 7855217

Sources:
TdgClinicalTrial DrugBank
EFAVIRENZ HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
23859571

Sources:
PharmGKB
LEVOMEPROMAZINE HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
15701205

Sources:
DrugBank
TRIMIPRAMINE HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
8863001

Sources:
DrugBank
IMIPRAMINE HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
7855217 16170231

Sources:
DrugBank
8-OH-DPAT HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Full agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
TRIFLUOPERAZINE HYDROCHLORIDE HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
VORTIOXETINE HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

Direct Interaction? False

PMIDs:
None found

Sources:
GuideToPharmacology
METHYLERGONOVINE HTR2A

Interaction Score: 0.03

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Endogenous Drug? False

Specific Action of the Ligand Full agonist

PMIDs:
None found

Sources:
GuideToPharmacology
CHEMBL609728 HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DrugBank
MAPROTILINE HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

binder

Interaction Info:

PMIDs:
7221567

Sources:
DrugBank
DESIPRAMINE HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
7855217

Sources:
DrugBank
TEDATIOXETINE HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

PMIDs:
None found

Sources:
ChemblInteractions
ROXINDOLE HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
CANNABIDIOL HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
28701957 26264914

Sources:
DrugBank
AMOXAPINE HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
8876023

Sources:
DrugBank
XANOMELINE HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Endogenous Drug? False

Specific Action of the Ligand Antagonist

PMIDs:
None found

Sources:
GuideToPharmacology
THIORIDAZINE HYDROCHLORIDE HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
PIMOZIDE HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Specific Action of the Ligand Antagonist

PMIDs:
None found

Sources:
GuideToPharmacology ChemblInteractions
HALOPERIDOL HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

other/unknown

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

Direct Interaction? True

PMIDs:
7520908 12629531

Sources:
DrugBank GuideToPharmacology ChemblInteractions
CHLORPROMAZINE HYDROCHLORIDE HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

PMIDs:
None found

Sources:
ChemblInteractions
SPIPERONE HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Endogenous Drug? False

Specific Action of the Ligand Antagonist

PMIDs:
None found

Sources:
GuideToPharmacology
METERGOLINE HTR2A

Interaction Score: 0.02

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
LAMOTRIGINE HTR2A

Interaction Score: 0.01

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

PMIDs:
22306746

Sources:
DrugBank
DULOXETINE HTR2A

Interaction Score: 0.01

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
METITEPINE HTR2A

Interaction Score: 0.01

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
PERPHENAZINE HTR2A

Interaction Score: 0.01

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
NABIXIMOLS HTR2A

Interaction Score: 0.01

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
26264914

Sources:
DrugBank
LITHIUM HTR2A

Interaction Score: 0.01

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10758249

Sources:
NCI
PROCHLORPERAZINE HTR2A

Interaction Score: 0.01

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TEND
TRIFLUOPERAZINE HTR2A

Interaction Score: 0.01

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

Direct Interaction? False

PMIDs:
None found

Sources:
GuideToPharmacology
FLUOXETINE HTR2A

Interaction Score: 0.01

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name NPL-2008, Fluoxetine

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial

Ensembl: ENSG00000102468
- Version: 101_38
Alternate Names:

HTR2A Ensembl Gene Name

Gene Info:

Gene Biotype PROTEIN_CODING

Publications:
TEND: P28223
- Version: 01-August-2011
Alternate Names:

P28223 Uniprot Accession

5HT2A_HUMAN Uniprot Id

HTR2A Gene Symbol

Gene Info:

Target Main Class Receptors

Target Subclass Rhodopsin

Transmembrane Helix Count 7

Publications:
RussLampel: ENSG00000102468
- Version: 26-July-2011
Alternate Names:

HTR2A Display Id

5-HYDROXYTRYPTAMINE 2A RECEPTOR (5-HT-2A) (SEROTONIN RECEPTOR 2A) (5- HT-2). [SOURCE:UNIPROT/SWISSPROT;ACC:P28223] Description

ENSG00000102468 Ensembl Gene Id

Gene Info:

Human Readable Name DRUGGABLE GENOME

Gene Categories:

DRUGGABLE GENOME

Publications:
HopkinsGroom: P28223
- Version: 11-September-2012
Alternate Names:

3356 Entrez Gene Id

5-HYDROXYTRYPTAMINE RECEPTOR 2A Uniprot Protein Name

HTR2A Uniprot Gene Name

Gene Info:

Human Readable Name G PROTEIN COUPLED RECEPTOR

Interpro Acc IPR000276

Uniprot Status Swiss-Prot

Gene Categories:

G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME

Publications:
TdgClinicalTrial: P28223
- Version: January-2014
Alternate Names:

HTR2A Gene Symbol

Gene Info:

Target Class Receptors

Target Subclass GPCR

Target Subclass Rhodopsin

Publications:
GuideToPharmacology: 3356
- Version: 29-September-2020
Alternate Names:

5293 HUGO Gene ID

5293 HUGO Gene Symbol

5-hydroxytryptamine receptor 2A HUGO Gene Name

Gene Info:

GuideToPharmacology Gene Category Name 5-Hydroxytryptamine receptors

GuideToPharmacology Gene Category ID 1

Gene Categories:

G PROTEIN COUPLED RECEPTOR

Publications:

PharmGKB: HTR2A

Version: 18-August-2020

Alternate Names:

PA193 PharmGKB ID

Gene Info:

Publications:

Tiwari AK et al., 2013, Analysis of 34 candidate genes in bupropion and placebo remission., Int J Neuropsychopharmacol

Ujike H et al., 2008, Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study., J Clin Psychiatry

Angelucci F et al., 2009, Delusion symptoms and response to antipsychotic treatment are associated with the 5-HT2A receptor polymorphism (102T/C) in Alzheimer's disease: a 3-year follow-up longitudinal study., J Alzheimers Dis

DrugBank: BE0004881
- Version: 5.1.7
Alternate Names:

HTR2A DrugBank Gene Name

P28223 UniProt Accession

3356 Entrez Gene Id

Gene Info:

Publications:

Roth et al., 1994, Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors., J. Pharmacol. Exp. Ther.

DrugBank: BE0004957

Version: 5.1.7

Alternate Names:

HTR2A DrugBank Gene Name

P28223 UniProt Accession

3356 Entrez Gene Id

Gene Info:

Publications:

Martin et al., 1982, Ketamine inhibits serotonin uptake in vivo., Neuropharmacology

Ivgy-May et al., 2015, Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial., Sleep Med.

DrugBank: BE0000451

Version: 5.1.7

Alternate Names:

HTR2A DrugBank Gene Name

P28223 UniProt Accession

3356 Entrez Gene Id

Gene Info:

Publications:

Prins et al., 2001, Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle., Br. J. Pharmacol.

Castilho et al., 1999, Antinociception elicited by aversive stimulation of the inferior colliculus., Pharmacol. Biochem. Behav.

Connor et al., 2001, Second messengers in platelet aggregation evoked by serotonin and A23187, a calcium ionophore., Life Sci.

TTD: 5-HT 2A receptor

Version: 2020.06.01

Alternate Names:

HTR2A TTD Gene Abbreviation

T32060 TTD Target ID

Gene Info:

Publications:

Guo JD et al., 2009, Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes., Neuroscience

Chen J et al., 2011, Novel ocular antihypertensive compounds in clinical trials., Clin Ophthalmol

NCI: HTR2A

Version: 14-September-2017

Alternate Names:

Gene Info:

Publications:

Serretti et al., Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders., J Psychiatr Res

Kasho et al., 1998, Serotonin enhances the production of type IV collagen by human mesangial cells., Kidney Int.

Arranz et al., 1996, Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine., Neurosci. Lett.

HingoraniCasas: ENSG00000102468
- Version: 31-May-2017
Alternate Names:

ENSG00000102468 Gene Symbol

HTR2A Ensembl Id

Gene Info:

Gene Categories:

DRUGGABLE GENOME

Publications:
ChemblInteractions: HTR2
- Version: chembl_23
Alternate Names:

HTR2 GENE_SYMBOL

HTR2A GENE_SYMBOL

5-hydroxytryptamine receptor 2A UNIPROT

Gene Info:

Publications:
Pharos: HTR2A
- Version: 03-September-2020
Alternate Names:

5-hydroxytryptamine receptor 2A Gene Name

P28223 UniProt ID

Gene Info:

Gene Categories:

KINASE

Publications:
GO: HTR2A
- Version: 05-September-2020
Alternate Names:

HTR2 GO Gene Synonym

Gene Info:

Gene Categories:

DRUG RESISTANCE, G PROTEIN COUPLED RECEPTOR

Publications:
dGene: HTR2A
- Version: 27-Jun-2013
Alternate Names:

3356 Gene ID

5-HT2A dGene Synonym

HTR2 dGene Synonym

Gene Info:

Gene Categories:

G PROTEIN COUPLED RECEPTOR

Publications:

Mechanism of Interaction	Serotonin 2a (5-HT2a) receptor inverse agonist
Direct Interaction	yes

Novel drug target	Established target
Trial Name	Pimavanserin
Details of the Assay for Interaction	Ki determined in membrane radioligand binding assay.

Mechanism of Interaction	Serotonin 2a (5-HT2a) receptor antagonist
Direct Interaction	yes

Trial Name	iferanserin ointment
Novel drug target	Established target
Mechanism of Interaction	Serotonin 2a (5-HT2a) receptor antagonist

Specific Action of the Ligand	Antagonist
Endogenous Drug?	False
Direct Interaction?	True

Trial Name	INN-00835, nemifitide
Novel drug target	Established target

Trial Name	esmirtazapine, ORG-4420
Novel drug target	Established target

Trial Name	lurasidone, SM-13496,Latuda
Novel drug target	Established target

Trial Name	paliperidone ER, paliperidone palmitate
Novel drug target	Established target
Mechanism of Interaction	Serotonin 2a (5-HT2a) receptor antagonist

Trial Name	Serdolect
Novel drug target	Established target
Specific Action of the Ligand	Antagonist

Specific Action of the Ligand	Full agonist
Endogenous Drug?	False

Specific Action of the Ligand	Agonist
Endogenous Drug?	False
Direct Interaction?	False

Trial Name	olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv
Novel drug target	Established target
Trial Name	Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac)

Specific Action of the Ligand	Partial agonist
Endogenous Drug?	False

Trial Name	Asenapine
Novel drug target	Established target
Specific Action of the Ligand	Antagonist

Trial Name	Silenor (SO-101)
Novel drug target	Established target

Specific Action of the Ligand	Inverse agonist
Endogenous Drug?	False
Direct Interaction?	True

Trial Name	bifeprunox, DU127090
Novel drug target	Established target

Trial Name	AZ-004
Novel drug target	Established target
Specific Action of the Ligand	Inverse agonist

Trial Name	NPL-2008, Fluoxetine
Novel drug target	Established target

HTR2A Gene Record

HTR2A 3356 Druggable GenomeDrug Resistance

Alternate Names:

Gene Info:

Gene Categories: Category Details

Publications:

Interaction Types & Directionality: inverse agonist (inhibitory)

Interaction Info: Mechanism of Interaction Serotonin 2a (5-HT2a) receptor inverse agonist Direct Interaction yes

PMIDs: None found

Sources: TTD DrugBank ChemblInteractions

Interaction Types & Directionality: inverse agonist (inhibitory) antagonist (inhibitory)

Interaction Info: Novel drug target Established target Trial Name Pimavanserin Details of the Assay for Interaction Ki determined in membrane radioligand binding assay.

PMIDs: 24016069

Sources: TdgClinicalTrial TTD DrugBank GuideToPharmacology

Interaction Types & Directionality: inverse agonist (inhibitory)

Interaction Info: Mechanism of Interaction Serotonin 2a (5-HT2a) receptor inverse agonist Direct Interaction yes

PMIDs: None found

Sources: TTD ChemblInteractions

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist Direct Interaction yes

PMIDs: None found

Sources: TTD ChemblInteractions

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Trial Name iferanserin ointment Novel drug target Established target Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

PMIDs: None found

Sources: TdgClinicalTrial ChemblInteractions

Interaction Types & Directionality: partial agonist (activating)

Interaction Info:

PMIDs: 15006903 17337633

Sources: DrugBank

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info:

PMIDs: 3816971 6086881 9537821

Sources: DrugBank

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Specific Action of the Ligand Antagonist Endogenous Drug? False Direct Interaction? True

PMIDs: 20030420

Sources: TTD DrugBank GuideToPharmacology

Interaction Types & Directionality: inverse agonist (inhibitory) antagonist (inhibitory)

Interaction Info: Endogenous Drug? False Specific Action of the Ligand Antagonist

PMIDs: 19672037 17031071

Sources: TTD DrugBank GuideToPharmacology

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 19278957 2540505

Sources: DrugBank

Interaction Types & Directionality: agonist (activating)

Interaction Info:

PMIDs: 11191631

Sources: DrugBank

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Specific Action of the Ligand Antagonist Endogenous Drug? False Trial Name volinanserin

PMIDs: None found

Sources: TdgClinicalTrial GuideToPharmacology ChemblInteractions

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist Direct Interaction yes

PMIDs: None found

Sources: DrugBank ChemblInteractions

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info:

PMIDs: 9562338 9211565

Sources: DrugBank

Interaction Types & Directionality: inverse agonist (inhibitory)

Interaction Info: Direct Interaction yes Mechanism of Interaction Serotonin 2a (5-HT2a) receptor inverse agonist

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Specific Action of the Ligand Antagonist Endogenous Drug? False

PMIDs: None found

Sources: GuideToPharmacology

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Specific Action of the Ligand Antagonist Endogenous Drug? False

PMIDs: None found

Sources: GuideToPharmacology

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info:

PMIDs: 10445375

Sources: DrugBank

Interaction Types & Directionality: n/a

Interaction Info: Trial Name INN-00835, nemifitide Novel drug target Established target

Interaction Types & Directionality:

inverse agonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor inverse agonist

Direct Interaction yes

PMIDs:
None found

Sources:
TTD DrugBank ChemblInteractions

Interaction Types & Directionality:

inverse agonist (inhibitory)

antagonist (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name Pimavanserin

Details of the Assay for Interaction Ki determined in membrane radioligand binding assay.

PMIDs:
24016069

Sources:
TdgClinicalTrial TTD DrugBank GuideToPharmacology

Interaction Types & Directionality:

inverse agonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor inverse agonist

Direct Interaction yes

PMIDs:
None found

Sources:
TTD ChemblInteractions

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
TTD ChemblInteractions

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name iferanserin ointment

Novel drug target Established target

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

PMIDs:
None found

Sources:
TdgClinicalTrial ChemblInteractions

Interaction Types & Directionality:

partial agonist (activating)

PMIDs:
15006903 17337633

Sources:
DrugBank

Interaction Types & Directionality:

antagonist (inhibitory)

PMIDs:
3816971 6086881 9537821

Sources:
DrugBank

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

Direct Interaction? True

PMIDs:
20030420

Sources:
TTD DrugBank GuideToPharmacology

Interaction Types & Directionality:

inverse agonist (inhibitory)

antagonist (inhibitory)

Interaction Info:

Endogenous Drug? False

Specific Action of the Ligand Antagonist

PMIDs:
19672037 17031071

Sources:
TTD DrugBank GuideToPharmacology

Interaction Types & Directionality:

n/a

PMIDs:
19278957 2540505

Sources:
DrugBank

Interaction Types & Directionality:

agonist (activating)

PMIDs:
11191631

Sources:
DrugBank

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

Trial Name volinanserin

PMIDs:
None found

Sources:
TdgClinicalTrial GuideToPharmacology ChemblInteractions

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
DrugBank ChemblInteractions

Interaction Types & Directionality:

antagonist (inhibitory)

PMIDs:
9562338 9211565

Sources:
DrugBank

Interaction Types & Directionality:

inverse agonist (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor inverse agonist

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology

Interaction Types & Directionality:

antagonist (inhibitory)

PMIDs:
10445375

Sources:
DrugBank

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name INN-00835, nemifitide

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

Direct Interaction? False

PMIDs:
11561066 15357957 10991983

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name trazodone extended release, DDS-04A,Oleptro

Specific Action of the Ligand Antagonist

PMIDs:
10594316 3039120 15610924 1365657 7855217 11714900 15614572 12782915

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name ITI-007, ITI-722

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

P28223	Uniprot Accession
5HT2A_HUMAN	Uniprot Id
HTR2A	Gene Symbol

HTR2A	Display Id
5-HYDROXYTRYPTAMINE 2A RECEPTOR (5-HT-2A) (SEROTONIN RECEPTOR 2A) (5- HT-2). [SOURCE:UNIPROT/SWISSPROT;ACC:P28223]	Description
ENSG00000102468	Ensembl Gene Id

3356	Entrez Gene Id
5-HYDROXYTRYPTAMINE RECEPTOR 2A	Uniprot Protein Name
HTR2A	Uniprot Gene Name

5293	HUGO Gene ID
5293	HUGO Gene Symbol
5-hydroxytryptamine receptor 2A	HUGO Gene Name

HTR2A	DrugBank Gene Name
P28223	UniProt Accession
3356	Entrez Gene Id

HTR2	GENE_SYMBOL
HTR2A	GENE_SYMBOL
5-hydroxytryptamine receptor 2A	UNIPROT